ѻý

Alzheimer's-Gut Links; Long COVID and ME/CFS; ALS Patient Gets Novel Brain Interface

<ѻý class="mpt-content-deck">— News and commentary from the world of neurology and neuroscience
MedpageToday
Brain scan images with NeuroBreak in the center.

Genome-wide association studies revealed and correlation between Alzheimer's disease and gastrointestinal tract disorders. (Communications Biology)

Depressive symptoms emerged in the years both incident stroke. (Neurology)

High adherence to a Mediterranean diet was associated with , and less learning and memory decline, among middle-age and older Hispanic or Latino adults. (JAMA Network Open)

The FDA approved the first of the anti-seizure medication zonisamide (Zonisade), Azurity Pharmaceuticals announced.

Quantitative MRI showed was associated with early Parkinson's disease. (Science Advances)

How might and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) be similar? (Frontiers in Neurology)

due to shift work was tied to stroke severity. (Neurobiology of Sleep and Circadian Rhythm)

More research -- this one in mice -- linked disease. (Frontiers in Aging Neuroscience)

Roche's Elecsys to help diagnose Alzheimer's disease won an FDA breakthrough device designation, the company said.

When patients became chronic opioid users, the risk for members doubled. (JAMA Network Open)

An ALS patient at Mount Sinai West in New York received the first in the U.S., device marker Synchron announced.

Restricting personal decisions on childbearing may for women with MS, epilepsy, and migraine. (JAMA Neurology)

A mouse study suggested where might be stored. (Nature)

  • Judy George covers neurology and neuroscience news for ѻý, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.